Acquired factor V inhibitors in a polytraumatized patient

Background. Factor V (FV) inhibitors are a rare disorder reported for the first time about fifty years ago, mostly with the unknown cause. The appearance of FV inhibitors is usually preceded by surgery, infections, administration of antibiotics or transfusions. Clinical manifestations of the presenc...

Full description

Saved in:
Bibliographic Details
Main Authors: Tukić Ljiljana, Stamatović Dragana, Tarabar Olivera, Elez Marija, Zorić Miodrag, Mandić-Radić Slavka
Format: Article
Language:English
Published: Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade 2005-01-01
Series:Vojnosanitetski Pregled
Subjects:
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2005/0042-84500508587T.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849396332453691392
author Tukić Ljiljana
Stamatović Dragana
Tarabar Olivera
Elez Marija
Zorić Miodrag
Mandić-Radić Slavka
author_facet Tukić Ljiljana
Stamatović Dragana
Tarabar Olivera
Elez Marija
Zorić Miodrag
Mandić-Radić Slavka
author_sort Tukić Ljiljana
collection DOAJ
description Background. Factor V (FV) inhibitors are a rare disorder reported for the first time about fifty years ago, mostly with the unknown cause. The appearance of FV inhibitors is usually preceded by surgery, infections, administration of antibiotics or transfusions. Clinical manifestations of the presence of FV inhibitors vary from mild to severe and in some instances fatal hemorrhage. Case report. A healthy 51-year-old man with severe multiple injuries (traffic accident), and hemorrhage, which occurred during the orthopedic treatment, was admitted with hemoptysis, epistaxis and hematoma of the right upper leg, and with prolonged prothrombin time (PT), and activated partial thromboplastin time (aPTT). Treatment with vitamin K, fresh-frozen plasma and cryoprecipitate stopped the hemorrhage, but the results of coagulation tests were not normalized. The correction of aPTT and PT with normal plasma showed the decreased activity of FV (1%) due to the presence of inhibitors (titer 17.5 IU). The abnormal results of coagulation tests remained for three weeks, but without clinically manifested hemorrhagic syndrome. At the fourth week after the appearance of FV inhibitors PT, aPTT and the activity of FV became normal and antibodies disappeared spontaneously. Conclusion. Our patient with polytrauma developed a mild hemorrhagic syndrome due to the presence of FV inhibitors five weeks after the accident. Hemorrhage was treated with substitution therapy. The cause of the development of FV inhibitors was unclear (“fibrin glue” was not used during the orthopedic treatment). Factor V inhibitors disappeared spontaneously within four weeks. The fast spontaneous disappearance of FV inhibitors in our patient, confirmed the observations of some authors that they disappeared faster in those patients who were surgically treated prior to their appearance.
format Article
id doaj-art-b453fd7baf684bc2b5af865ec1146957
institution Kabale University
issn 0042-8450
language English
publishDate 2005-01-01
publisher Ministry of Defence of the Republic of Serbia, University of Defence, Belgrade
record_format Article
series Vojnosanitetski Pregled
spelling doaj-art-b453fd7baf684bc2b5af865ec11469572025-08-20T03:39:22ZengMinistry of Defence of the Republic of Serbia, University of Defence, BelgradeVojnosanitetski Pregled0042-84502005-01-01627-858759010.2298/VSP0508587TAcquired factor V inhibitors in a polytraumatized patientTukić LjiljanaStamatović DraganaTarabar OliveraElez MarijaZorić MiodragMandić-Radić SlavkaBackground. Factor V (FV) inhibitors are a rare disorder reported for the first time about fifty years ago, mostly with the unknown cause. The appearance of FV inhibitors is usually preceded by surgery, infections, administration of antibiotics or transfusions. Clinical manifestations of the presence of FV inhibitors vary from mild to severe and in some instances fatal hemorrhage. Case report. A healthy 51-year-old man with severe multiple injuries (traffic accident), and hemorrhage, which occurred during the orthopedic treatment, was admitted with hemoptysis, epistaxis and hematoma of the right upper leg, and with prolonged prothrombin time (PT), and activated partial thromboplastin time (aPTT). Treatment with vitamin K, fresh-frozen plasma and cryoprecipitate stopped the hemorrhage, but the results of coagulation tests were not normalized. The correction of aPTT and PT with normal plasma showed the decreased activity of FV (1%) due to the presence of inhibitors (titer 17.5 IU). The abnormal results of coagulation tests remained for three weeks, but without clinically manifested hemorrhagic syndrome. At the fourth week after the appearance of FV inhibitors PT, aPTT and the activity of FV became normal and antibodies disappeared spontaneously. Conclusion. Our patient with polytrauma developed a mild hemorrhagic syndrome due to the presence of FV inhibitors five weeks after the accident. Hemorrhage was treated with substitution therapy. The cause of the development of FV inhibitors was unclear (“fibrin glue” was not used during the orthopedic treatment). Factor V inhibitors disappeared spontaneously within four weeks. The fast spontaneous disappearance of FV inhibitors in our patient, confirmed the observations of some authors that they disappeared faster in those patients who were surgically treated prior to their appearance.http://www.doiserbia.nb.rs/img/doi/0042-8450/2005/0042-84500508587T.pdfblood coagulation disordersblood coagulation factorshematologic testsmultiple trauma
spellingShingle Tukić Ljiljana
Stamatović Dragana
Tarabar Olivera
Elez Marija
Zorić Miodrag
Mandić-Radić Slavka
Acquired factor V inhibitors in a polytraumatized patient
Vojnosanitetski Pregled
blood coagulation disorders
blood coagulation factors
hematologic tests
multiple trauma
title Acquired factor V inhibitors in a polytraumatized patient
title_full Acquired factor V inhibitors in a polytraumatized patient
title_fullStr Acquired factor V inhibitors in a polytraumatized patient
title_full_unstemmed Acquired factor V inhibitors in a polytraumatized patient
title_short Acquired factor V inhibitors in a polytraumatized patient
title_sort acquired factor v inhibitors in a polytraumatized patient
topic blood coagulation disorders
blood coagulation factors
hematologic tests
multiple trauma
url http://www.doiserbia.nb.rs/img/doi/0042-8450/2005/0042-84500508587T.pdf
work_keys_str_mv AT tukicljiljana acquiredfactorvinhibitorsinapolytraumatizedpatient
AT stamatovicdragana acquiredfactorvinhibitorsinapolytraumatizedpatient
AT tarabarolivera acquiredfactorvinhibitorsinapolytraumatizedpatient
AT elezmarija acquiredfactorvinhibitorsinapolytraumatizedpatient
AT zoricmiodrag acquiredfactorvinhibitorsinapolytraumatizedpatient
AT mandicradicslavka acquiredfactorvinhibitorsinapolytraumatizedpatient